Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2.
Waardenburg syndrome (WS) is a rare auditory-pigmentary disorder that exhibits varying combinations of sensorineural hearing loss and pigmentation defects. Four subtypes are clinically defined based on the presence or absence of additional symptoms. WS type 2 (WS2) can result from mutations within t...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3407046?pdf=render |
| _version_ | 1819059026754797568 |
|---|---|
| author | Viviane Baral Asma Chaoui Yuli Watanabe Michel Goossens Tania Attie-Bitach Sandrine Marlin Veronique Pingault Nadege Bondurand |
| author_facet | Viviane Baral Asma Chaoui Yuli Watanabe Michel Goossens Tania Attie-Bitach Sandrine Marlin Veronique Pingault Nadege Bondurand |
| author_sort | Viviane Baral |
| collection | DOAJ |
| description | Waardenburg syndrome (WS) is a rare auditory-pigmentary disorder that exhibits varying combinations of sensorineural hearing loss and pigmentation defects. Four subtypes are clinically defined based on the presence or absence of additional symptoms. WS type 2 (WS2) can result from mutations within the MITF or SOX10 genes; however, 70% of WS2 cases remain unexplained at the molecular level, suggesting that other genes might be involved and/or that mutations within the known genes escaped previous screenings. The recent identification of a deletion encompassing three of the SOX10 regulatory elements in a patient presenting with another WS subtype, WS4, defined by its association with Hirschsprung disease, led us to search for deletions and point mutations within the MITF and SOX10 regulatory elements in 28 yet unexplained WS2 cases. Two nucleotide variations were identified: one in close proximity to the MITF distal enhancer (MDE) and one within the U1 SOX10 enhancer. Functional analyses argued against a pathogenic effect of these variations, suggesting that mutations within regulatory elements of WS genes are not a major cause of this neurocristopathy. |
| first_indexed | 2024-12-21T14:04:33Z |
| format | Article |
| id | doaj.art-887993fbb8524c1a95d24f9941a5442d |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T14:04:33Z |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-887993fbb8524c1a95d24f9941a5442d2022-12-21T19:01:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0177e4192710.1371/journal.pone.0041927Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2.Viviane BaralAsma ChaouiYuli WatanabeMichel GoossensTania Attie-BitachSandrine MarlinVeronique PingaultNadege BondurandWaardenburg syndrome (WS) is a rare auditory-pigmentary disorder that exhibits varying combinations of sensorineural hearing loss and pigmentation defects. Four subtypes are clinically defined based on the presence or absence of additional symptoms. WS type 2 (WS2) can result from mutations within the MITF or SOX10 genes; however, 70% of WS2 cases remain unexplained at the molecular level, suggesting that other genes might be involved and/or that mutations within the known genes escaped previous screenings. The recent identification of a deletion encompassing three of the SOX10 regulatory elements in a patient presenting with another WS subtype, WS4, defined by its association with Hirschsprung disease, led us to search for deletions and point mutations within the MITF and SOX10 regulatory elements in 28 yet unexplained WS2 cases. Two nucleotide variations were identified: one in close proximity to the MITF distal enhancer (MDE) and one within the U1 SOX10 enhancer. Functional analyses argued against a pathogenic effect of these variations, suggesting that mutations within regulatory elements of WS genes are not a major cause of this neurocristopathy.http://europepmc.org/articles/PMC3407046?pdf=render |
| spellingShingle | Viviane Baral Asma Chaoui Yuli Watanabe Michel Goossens Tania Attie-Bitach Sandrine Marlin Veronique Pingault Nadege Bondurand Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2. PLoS ONE |
| title | Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2. |
| title_full | Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2. |
| title_fullStr | Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2. |
| title_full_unstemmed | Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2. |
| title_short | Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2. |
| title_sort | screening of mitf and sox10 regulatory regions in waardenburg syndrome type 2 |
| url | http://europepmc.org/articles/PMC3407046?pdf=render |
| work_keys_str_mv | AT vivianebaral screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 AT asmachaoui screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 AT yuliwatanabe screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 AT michelgoossens screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 AT taniaattiebitach screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 AT sandrinemarlin screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 AT veroniquepingault screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 AT nadegebondurand screeningofmitfandsox10regulatoryregionsinwaardenburgsyndrometype2 |